Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+6.42%
Monthly Change
-13.43%
6 month change
+346.15%
Cambio anual
+256.92%
Cierres anteriores
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
Volumen
15
Markets
Acciones
Atención Sanitaria
IPSC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
85.03 M
86.05 M
86.16 M
86.39 M
87.31 M
—
Valuation ratios
Enterprise value
92.81 M
28.46 M
-10.85 M
-8.61 M
-12.04 M
-3.04 M
Price to earnings ratio
-0.93
-0.63
-1.76
-2.07
-1.66
-6.12
Price to sales ratio
43.4
12.06
0.35
0.42
0.38
13.21
Price to cash flow ratio
-1.01
-0.72
-0.33
-0.4
-0.38
-1.82
Price to book ratio
0.15
0.49
0.05
0.06
0.05
0.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.08
0.1
0.24
0.11
0.14
0.6
Return on equity %
0.16
0.22
0.32
0.16
0.2
0.89
Return on invested capital %
67.18
67.16
138.89
98.45
114.82
419.32
Gross margin %
100
100
100
—
—
—
Operating margin %
4 398.1
893.67
67.95
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
3 947.66
864.65
70.13
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.39
1.5
11.7
10.72
6.25
30.16
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0.33
0
0
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.33
0.31
0.4
0.32
0.3
1.33
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.34
2.41
1.92
1.81
1.54
7.67
Net current asset value per share
2.43
2.47
1.97
1.86
1.59
7.89
Tangible book value per share
1.86
1.62
2.4
2.04
1.64
7.69
Working capital per share
2.2
0.82
1.8
1.68
1.34
5.64
Book value per share
2.31
2.05
2.79
2.43
2.04
9.32
Noticias
TD Cowen initiates Century Therapeutics stock rating at Buy
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors
Century Therapeutics appoints two new board members
Century Therapeutics stock downgraded by Leerink Partners on lack of catalysts
Century Therapeutics unveils T1D therapy program with immune evasion tech